Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Weill Cornell reports new findings from IVIG Phase 3 trial in Alzheimer's disease at AAIC 2013

Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings today from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease at the Alzheimer's Association International Conference in Boston, Mass.

16 Jul 2013

Semi-quantitative pregnancy tests: an interview with Dr. Paul Blumenthal, Stanford University School of Medicine

Regular pregnancy tests work a little bit like a simple light switch that you have on your wall. It’s either on or off. When it’s on, that means the test is positive; if it’s off, obviously, it’s negative.

12 Jul 2013

General DNA sequencing can reveal previously undetectable viruses

There are 170 established HPV types. Cancerous human papillomavirus (HPV) viruses are the main cause of cervical cancer, and are found in close to 100% of cervical tumors.

12 Jul 2013

State highlights: Disabled at risk at Calif. facilities, audit finds; Advocates push for single policy for kids' medical, dental coverage in exchange plans; Ga. maternal mortality

Californians with developmental disabilities who are cared for at state facilities are being put at risk by outdated policies and inadequate investigations of abuse, the state auditor's office said Tuesday. Allegations that residents have been raped, shot with stun guns and otherwise abused have not been acted on satisfactorily, auditors found. The California Department of Developmental Services cares for 1,480 severely disabled people in five facilities throughout the state (McGreevy, 7/9).

11 Jul 2013

Age-old practice of annual screening exams for cervical cancer may be harmful than helpful

For decades, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer. In 2009, however, accumulating scientific evidence led major guideline groups to agree on a new recommendation that women be screened less frequently: every three years rather than annually.

10 Jul 2013

Cancer immunotherapies promise to be a new tool in fight against cancer

Drugs that direct a cancer patient's immune system to eradicate her or his disease, known as cancer immunotherapies, promise to be a new tool in the fight against cancer. Since the Koch Institute's inception, exploring the close relationship between the immune system and cancer has been one of the Institute's priority research areas.

9 Jul 2013

Study shows very few physicians follow HPV and cervical cancer prevention guidelines

Recent breakthroughs in cervical cancer prevention have resulted in new vaccination and cervical cancer screening guidelines. Recommendations do not always translate into practice, however.

9 Jul 2013

3-gene signature test will improve care of kidney transplant patients

A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).

4 Jul 2013

Viewpoints: Late hospital bills perplex consumers; Personal health data can 'revolutionize' care

Flavio de Pecol hit the trifecta after taking his daughter to the emergency room for a horse-riding injury: hours of waiting, a 16-mile ambulance ride to a different facility and bills for more than $40,000. At least, he thought, that was the end of it. But nearly two years (later), ... De Pecol, of Newport Beach, has received yet another bill, this time for $1,054.53. ... "How can I trust that this isn't a mistake when a hospital takes 21 months to bill me?" De Pecol asked. ... Good questions, and yet another example of the way consumers are at the mercy of the healthcare industry's opaque and byzantine billing practices (David Lazarus, 6/25).

28 Jun 2013

Weill Cornell researchers discover high burden of hypertension in sub-Saharan African country

Based on the experience of a large hospital in Tanzania, Weill Cornell Medical College researchers have discovered a "startlingly" high burden of hypertension in this sub-Saharan African country.

26 Jun 2013

Advaxis seeks ADXS-HPV Orphan Drug Designation for treatment of HPV-associated anal cancer

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has submitted an Application for Orphan Drug Designation with the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated anal cancer.

25 Jun 2013

Weill Cornell public health study sheds light on hidden cost of terrorism

The 9/11 attacks on America appear to have caused about one million former smokers across the country to take up the habit again and maintain it, according to a Weill Cornell Medical College public health study.

21 Jun 2013

Genetic process that promotes cervical cancer warns about anti-viral therapies in certain cases

A new understanding of the genetic process that can lead to cervical cancer may help improve diagnosis of potentially dangerous lesions for some women, and also raises a warning flag about the use of anti-viral therapies in certain cases - suggesting they could actually trigger the cancer they are trying to cure.

20 Jun 2013

First Edition: June 20, 2013

Today's headlines include a variety of reports about the health law's implementation as well as related developments from Capitol Hill.

20 Jun 2013

New framework to improve safety and effectiveness of surgical procedures, implantable devices

An international team of investigators co-led by Weill Cornell Medical College is offering a new framework for evidence-based surgery and device research, similar to the kind of risk and benefit analysis used in evidence-based medicine.

19 Jun 2013

Medical experts spot cancerous abnormalities on medical images in a single glance

Have you ever thought that you knew something about the world in the blink of an eye? This restaurant is not the right place for dinner. That person could be The One. It turns out that radiologists can do this with mammograms, the x-ray images used for breast cancer screening. Cytologists, who screen micrographic images of cervical cells to detect cervical cancer, have a similar ability. A new study, published in Springer's journal Psychonomic Bulletin & Review, takes a closer look at the skill these specialists have.

18 Jun 2013

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.

10 Jun 2013

Nation's leading experts join forces to accelerate effective treatments for brain tumors

The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest emerging therapies, as the Weill Cornell Brain and Spine Center and Voices Against Brain Cancer hosted its second annual Brain Tumor Biotech Summit.

10 Jun 2013

Study sheds light on origin of wide range of brain disorders

Researchers at Weill Cornell Medical College have uncovered a mechanism that guides the exquisite wiring of neural circuits in a developing brain -- gaining unprecedented insight into the faulty circuits that may lead to brain disorders ranging from autism to mental retardation.

10 Jun 2013

Early detection methods can help cure cervical cancer

Cervical cancer, a disease that will affect more than 12,000 women in the United States this year and more than a half million women worldwide, leads to significantly fewer deaths when effective early detection methods are available, either via a Pap smear or with a test for presence of the human papilloma virus.

4 Jun 2013

Cervical Cancer News and Research

Further Reading

Weill Cornell reports new findings from IVIG Phase 3 trial in Alzheimer's disease at AAIC 2013

Semi-quantitative pregnancy tests: an interview with Dr. Paul Blumenthal, Stanford University School of Medicine

General DNA sequencing can reveal previously undetectable viruses

State highlights: Disabled at risk at Calif. facilities, audit finds; Advocates push for single policy for kids' medical, dental coverage in exchange plans; Ga. maternal mortality

Age-old practice of annual screening exams for cervical cancer may be harmful than helpful

Cancer immunotherapies promise to be a new tool in fight against cancer

Study shows very few physicians follow HPV and cervical cancer prevention guidelines

3-gene signature test will improve care of kidney transplant patients

Viewpoints: Late hospital bills perplex consumers; Personal health data can 'revolutionize' care

Weill Cornell researchers discover high burden of hypertension in sub-Saharan African country

Advaxis seeks ADXS-HPV Orphan Drug Designation for treatment of HPV-associated anal cancer

Weill Cornell public health study sheds light on hidden cost of terrorism

Genetic process that promotes cervical cancer warns about anti-viral therapies in certain cases

First Edition: June 20, 2013

New framework to improve safety and effectiveness of surgical procedures, implantable devices

Medical experts spot cancerous abnormalities on medical images in a single glance

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

Nation's leading experts join forces to accelerate effective treatments for brain tumors

Study sheds light on origin of wide range of brain disorders

Early detection methods can help cure cervical cancer

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News